Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
July 15, 2024
Fatty acid oxidation in immune function
Felicia Kemp, Erica L Braverman, Craig A Byersdorfer
Frontiers in Immunology
|
March 21, 2025
Nuclear receptor 4A1 is critical for neutrophil-dependent pulmonary immunity to <i>Klebsiella pneumoniae</i> infection
Norie Sugitani, Matthew Henkel, Jessica Partyka, et al.
Blood Advances
|
May 29, 2024
AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease
Archana Ramgopal, Erica L Braverman, Lee-Kai Sun, et al.
Plos One
|
February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
Susan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
AMPK agonism optimizes the <i>in vivo</i> persistence and anti-leukemia efficacy of chimeric antigen receptor T cells
Erica L Braverman, Mengtao Qin, Herbert Schuler, et al.
The Journal of Biological Chemistry
|
November 24, 2023
Overexpression of AMPKγ2 increases AMPK signaling to augment human T cell metabolism and function
Erica L Braverman, Margaret A McQuaid, Herbert Schuler, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
AMPK agonism optimizes the in vivo activation and antileukemic efficacy of chimeric antigen receptor T cells
Erica Braverman, Mengtao Qin, Elisabet Ampudia-Mesias, et al.
Science Translational Medicine
|
February 19, 2025
Dysfunctional CD11c<sup>-</sup>CD21<sup>-</sup> extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer
Ayana T Ruffin, Allison N Casey, Sheryl R Kunning, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
July 15, 2024
Fatty acid oxidation in immune function
Felicia Kemp, Erica L Braverman, Craig A Byersdorfer
Frontiers in Immunology
|
March 21, 2025
Nuclear receptor 4A1 is critical for neutrophil-dependent pulmonary immunity to <i>Klebsiella pneumoniae</i> infection
Norie Sugitani, Matthew Henkel, Jessica Partyka, et al.
Blood Advances
|
May 29, 2024
AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease
Archana Ramgopal, Erica L Braverman, Lee-Kai Sun, et al.
Plos One
|
February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
Susan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Biorxiv : the Preprint Server for Biology
|
October 10, 2024
AMPK agonism optimizes the <i>in vivo</i> persistence and anti-leukemia efficacy of chimeric antigen receptor T cells
Erica L Braverman, Mengtao Qin, Herbert Schuler, et al.
The Journal of Biological Chemistry
|
November 24, 2023
Overexpression of AMPKγ2 increases AMPK signaling to augment human T cell metabolism and function
Erica L Braverman, Margaret A McQuaid, Herbert Schuler, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
AMPK agonism optimizes the in vivo activation and antileukemic efficacy of chimeric antigen receptor T cells
Erica Braverman, Mengtao Qin, Elisabet Ampudia-Mesias, et al.
Science Translational Medicine
|
February 19, 2025
Dysfunctional CD11c<sup>-</sup>CD21<sup>-</sup> extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer
Ayana T Ruffin, Allison N Casey, Sheryl R Kunning, et al.
Nature Cancer
|
June 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy
Dong Hu, Xiaoshuang Lyu, Zheqi Li, et al.
Page
of 1